The SWITCH1 trial: Proving that Lantus/Basaglar has a higher Hypocglycaemia rate than Tresiba
Let’s start with the SWITCH 1 trial. What is it? It was a Phase 3a trial to compare the hypoglycaemia benefit of the two insulins. […]
Let’s start with the SWITCH 1 trial. What is it? It was a Phase 3a trial to compare the hypoglycaemia benefit of the two insulins. […]
Copyright © 2024 | WordPress Theme by MH Themes